Philips completes acquisition of The Spectranetics Corporation

Amsterdam, the Netherlands and Colorado Springs, CO, U.S. – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today announced that it has completed the acquisition of The Spectranetics Corporation (NASDAQ: SPNC), a U.S.-based global leader in vascular intervention and lead management solutions. Spectranetics’ financial results will be consolidated as part of […]

HeartFlow Announces Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on Non-Invasive HeartFlow® FFRct Analysis for Coronary Artery Disease

REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow, Inc. today announced that Horizon Blue Cross Blue Shield of New Jersey (Horizon BCBSNJ), Blue Cross Blue Shield of Arizona, Blue Cross of Idaho and Blue Cross Blue Shield of Kansas City have each issued a positive medical policy for the HeartFlow® FFRct Analysis, a first-of-its-kind noninvasive technology […]

Penumbra, Inc. Reports Second Quarter 2017 Financial Results

ALAMEDA, Calif., Aug. 8, 2017 /PRNewswire/ — Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on interventional therapies, today reported financial results for the second quarter ended June 30, 2017. Revenue of $80.6 million in the second quarter of 2017, an increase of 23.8%, or 24.6% in constant currency1, over the second quarter of 2016. […]

Researchers receive $1.5 million each to study extracellular matrix for cardiovascular research

DALLAS, Aug. 9, 2017 /PRNewswire/ — Two researchers have been awarded grants that could help uncover the next breakthrough in heart-health research, the American Heart Association and The Paul G. Allen Frontiers Group announced Wednesday.  Suneel Apte at the Cleveland Clinic and Jeffrey Holmes at the University of Virginia have been awarded $1.5 million each to study the extracellular matrix […]

Bard Shareholders Approve Proposed Merger With Becton, Dickinson

MURRAY HILL, N.J. and FRANKLIN LAKES, N.J., Aug. 8, 2017 /PRNewswire/ — C. R. Bard, Inc. (NYSE: BCR) (“Bard”) and Becton, Dickinson and Company (NYSE: BDX) (“BD”) today announced the results of Bard’s special meeting of shareholders, held on August 8, 2017 and at which a quorum was present, for Bard shareholders to consider and vote upon the proposed […]

Corindus Vascular Robotics Reports Second Quarter 2017 Results

WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, today reported financial results for the quarter ended June 30, 2017. Recent Highlights and Accomplishments Revenue of $2.3 million in the second quarter 2017 Increased CorPath® GRX installed base to 16 systems with three new […]

CeloNova BioSciences Announces Financing Arrangement with Congruent Investment Partners and SWK Holdings Corporation

CeloNova BioSciences Announces Financing Arrangement with Congruent Investment Partners and SWK Holdings Corporation Proceeds to Support Company Growth, Ongoing Clinical Trial Enrollment and New Product Initiatives CeloNova BioSciences, Inc. (CeloNova), a medical device company that develops, manufactures and markets a family of innovative cardiovascular products based upon its novel Polyzene™-F […]

LivaNova (LIVN)’s Perceval Sutureless Aortic Heart Valve Awarded New Technology Add-On Payment From The Center For Medicare And Medicaid Services

LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, today announced its Perceval® sutureless aortic heart valve received approval from the Centers for Medicare and Medicaid Services (CMS) for a New Technology Add-on Payment (NTAP). The Perceval valve met the CMS criteria for NTAP, including the demonstration […]